Supplemental Data
Files in this Data Supplement:
- Supplemental Figures -
Supplemental Figure 1 - Chemical structures of vandetanib (A), gefitinib (B), erlotinib (C), and lapatinib (D)
Supplemental Figure 2 - Comparison of IC50 values for the inhibition of OCT2-mediated MPP+ uptake versus inhibition of OCT2-mediated metformin uptake (A) and MPP+/metformin IC50 ratios (B).